PubMed:23883922
Annnotations
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 253-279 | HP_0030358 | denotes | non-small-cell lung cancer |
T2 | 257-279 | HP_0030357 | denotes | small-cell lung cancer |
T3 | 268-279 | HP_0100526 | denotes | lung cancer |
T4 | 273-279 | HP_0002664 | denotes | cancer |
T5 | 343-350 | HP_0002664 | denotes | tumours |
Allie
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
SS1_23883922_2_0 | 253-279 | expanded | denotes | non-small-cell lung cancer |
SS2_23883922_2_0 | 281-286 | abbr | denotes | NSCLC |
SS1_23883922_16_0 | 1612-1624 | expanded | denotes | hazard ratio |
SS2_23883922_16_0 | 1626-1628 | abbr | denotes | HR |
AE1_23883922_2_0 | SS1_23883922_2_0 | SS2_23883922_2_0 | abbreviatedTo | non-small-cell lung cancer,NSCLC |
AE1_23883922_16_0 | SS1_23883922_16_0 | SS2_23883922_16_0 | abbreviatedTo | hazard ratio,HR |
yangbin123xm_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 78-104 | DP | denotes | non-small-cell lung cancer |
T10 | 0-9 | CI | denotes | Erlotinib |
T11 | 185-194 | CI | denotes | Erlotinib |
T12 | 17-26 | CI | denotes | docetaxel |
T13 | 839-848 | CI | denotes | docetaxel |
T14 | 1446-1455 | CI | denotes | docetaxel |
T15 | 1549-1558 | CI | denotes | docetaxel |
T16 | 1719-1728 | CI | denotes | docetaxel |
T17 | 1820-1829 | CI | denotes | docetaxel |
T18 | 2019-2028 | CI | denotes | docetaxel |
T19 | 808-817 | CI | denotes | erlotinib |
T2 | 253-279 | DP | denotes | non-small-cell lung cancer |
T20 | 449-458 | CI | denotes | erlotinib |
T21 | 1475-1484 | CI | denotes | erlotinib |
T22 | 1592-1601 | CI | denotes | erlotinib |
T23 | 1739-1748 | CI | denotes | erlotinib |
T24 | 1863-1872 | CI | denotes | erlotinib |
T25 | 2057-2066 | CI | denotes | erlotinib |
T26 | 2226-2235 | CI | denotes | erlotinib |
T3 | 281-286 | DP | denotes | NSCLC |
T4 | 641-646 | DP | denotes | NSCLC |
T5 | 2299-2304 | DP | denotes | NSCLC |
T6 | 109-131 | DP | denotes | wild-type EGFR tumours |
T7 | 2314-2336 | DP | denotes | wild-type EGFR tumours |
T8 | 355-369 | DP | denotes | EGFR wild-type |
T9 | 693-707 | DP | denotes | wild-type EGFR |
chenxin_473849_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 253-279 | DP | denotes | non-small-cell lung cancer |
T10 | 1475-1484 | CI | denotes | erlotinib |
T11 | 1592-1601 | CI | denotes | erlotinib |
T12 | 1739-1748 | CI | denotes | erlotinib |
T13 | 1863-1872 | CI | denotes | erlotinib |
T14 | 2057-2066 | CI | denotes | erlotinib |
T15 | 2226-2235 | CI | denotes | erlotinib |
T16 | 839-848 | CI | denotes | docetaxel |
T17 | 17-26 | CI | denotes | docetaxel |
T18 | 1446-1455 | CI | denotes | docetaxel |
T19 | 1549-1558 | CI | denotes | docetaxel |
T2 | 78-104 | DP | denotes | non-small-cell lung cancer |
T20 | 1719-1728 | CI | denotes | docetaxel |
T21 | 1820-1829 | CI | denotes | docetaxel |
T22 | 2019-2028 | CI | denotes | docetaxel |
T23 | 109-131 | DP | denotes | wild-type EGFR tumours |
T24 | 2314-2336 | DP | denotes | wild-type EGFR tumours |
T26 | 693-707 | DP | denotes | wild-type EGFR |
T3 | 281-286 | DP | denotes | NSCLC |
T4 | 641-646 | DP | denotes | NSCLC |
T5 | 2299-2304 | DP | denotes | NSCLC |
T6 | 0-9 | CI | denotes | Erlotinib |
T7 | 185-194 | CI | denotes | Erlotinib |
T8 | 449-458 | CI | denotes | erlotinib |
T9 | 808-817 | CI | denotes | erlotinib |
T27 | 355-369 | DP | denotes | EGFR wild-type |